Manager × security

PZENA INVESTMENT MANAGEMENT LLC CVS holdings history

Who else holds this security? →

CVS HEALTH CORP · CUSIP 126650100 · CIK 1027796

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, PZENA INVESTMENT MANAGEMENT LLC reported 11.77M CVS (shares), valued at $1.22B, or 3.57% of its reported non-derivative portfolio. Filed 2026-08-07.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
3.57%
Shares
11.77M
11,769,536
Reported value
$1.22B
USD

Shares decreased 14.55%; reported value increased 23.09%, and weight changed +0.36 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20263.57%11,769,536SEC filing ↗Filed Aug 7, 2026Combination report
Q1 20263.21%13,773,053SEC filing ↗Filed Apr 24, 2026Combination report
Q4 20253.70%15,581,307SEC filing ↗Filed Feb 6, 2026Combination report
Q3 20253.86%15,844,972SEC filing ↗Filed Nov 7, 2025Combination report
Q2 20253.76%16,746,853SEC filing ↗Filed Jul 25, 2025Combination report
Q1 20254.18%17,682,374SEC filing ↗Filed May 2, 2025Combination report
Q4 20243.00%19,610,579SEC filing ↗Filed Feb 7, 2025Combination report
Q3 20242.66%13,135,308SEC filing ↗Filed Nov 8, 2024Combination report
Q2 20242.69%12,936,388SEC filing ↗Filed Aug 2, 2024Combination report
Q1 20241.52%5,553,457SEC filing ↗Filed May 3, 2024Combination report
Q4 20230.24%824,250SEC filing ↗Filed Feb 9, 2024Combination report

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20230.24%824,250$65.08MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 9, 2024
Q1 20241.52%5,553,457$442.94MShares increased 573.76%; reported value increased 580.59%, and weight changed +1.28 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 3, 2024
Q2 20242.69%12,936,388$764.02MShares increased 132.94%; reported value increased 72.49%, and weight changed +1.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 2, 2024
Q3 20242.66%13,135,308$825.95MShares increased 1.54%; reported value increased 8.11%, and weight changed -0.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 8, 2024
Q4 20243.00%19,610,579$880.32MShares increased 49.30%; reported value increased 6.58%, and weight changed +0.34 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 7, 2025
Q1 20254.18%17,682,374$1.20BShares decreased 9.83%; reported value increased 36.08%, and weight changed +1.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 2, 2025
Q2 20253.76%16,746,853$1.16BShares decreased 5.29%; reported value decreased 3.57%, and weight changed -0.42 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 25, 2025
Q3 20253.86%15,844,972$1.19BShares decreased 5.39%; reported value increased 3.41%, and weight changed +0.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 7, 2025
Q4 20253.70%15,581,307$1.24BShares decreased 1.66%; reported value increased 3.51%, and weight changed -0.16 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 6, 2026
Q1 20263.21%13,773,053$989.18MShares decreased 11.61%; reported value decreased 20.00%, and weight changed -0.49 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 24, 2026
Q2 20263.57%11,769,536$1.22BShares decreased 14.55%; reported value increased 23.09%, and weight changed +0.36 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 7, 2026
PZENA INVESTMENT MANAGEMENT LLC · CVS HEALTH CORP

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1027796","quarter":"2026Q2","cusip":"126650100"}

get_institutional_manager_history
{"cik":"1027796","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.